NCT03448380 - FreeStyle Libre Flash Glucose Monitoring System Post Approval Study | Biotech Hunter

Enrollment

935

Participants

Timeline

Start Date

February 27, 2018

Primary Completion Date

March 30, 2021

Study Completion Date

March 30, 2021

Conditions

Diabetes Mellitus

Interventions

DEVICE

FreeStyle Libre Flash Glucose Monitoring System

Subjects will utilize capillary SMBG for managing diabetes for 6 months (control phase) followed by diabetes management using FreeStyle Libre for 6 months (intervention phase).

Trial Locations (10)

33156

Baptist Diabetes Associates, P.A, Miami

33401

Metabolic Research Institute, West Palm Beach

48202

Henry Ford Medical Center, Detroit

50265

Iowa Diabetes & Endocrinology Research Center, Des Moines

78229

Clinical Trials of Texas, San Antonio

78681

Texas Diabetes & Endocrinology, Round Rock

83404

Rocky Mountain Diabetes & Osteoporosis Center, Idaho Falls

87109

Albuquerque Neuroscience Inc., Albuquerque

93105

Sansum Diabetes Research Institute, Santa Barbara

02453

MassResearch, LLC, Waltham